Jérémie Zerbit
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
- Oncology 11
- COVID-19 and healthcare impacts 3
- CAR-T cell therapy research 2
- Viral-associated cancers and disorders 2
-
- Multiple Myeloma Research and Treatments 2
- Chronic Myeloid Leukemia Treatments 2
- Co-authors
- Justine Decroocq (7 shared papers)Didier Bouscary (6 shared papers)Jérôme Clerc (2 shared papers)Rudy Birsen (5 shared papers)Olivier Huillard (2 shared papers)Simon Garinet (2 shared papers)Béatrix Cochand‐Priollet (2 shared papers)Lionel Groussin (2 shared papers)
- Journals
- Thyroid (2 papers)Cell Death Discovery (1 paper)EClinicalMedicine (1 paper)Supportive Care in Cancer (1 paper)Frontiers in Medicine (1 paper)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Jérémie Zerbit
21 papers receiving 1.1k citations
Jérémie Zerbit's Hit Papers
Peers
Comparison fields: 5 of 84
- Infectious Diseases 611
- Neurology 292
- Critical Care and Intensive Care Medicine 32
- Hematology 69
- Oncology 119
Countries citing papers authored by Jérémie Zerbit
This map shows the geographic impact of Jérémie Zerbit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérémie Zerbit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérémie Zerbit more than expected).
Fields of papers citing papers by Jérémie Zerbit
This network shows the impact of papers produced by Jérémie Zerbit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérémie Zerbit. The network helps show where Jérémie Zerbit may publish in the future.
Co-authors
The 25 scholars most cited alongside Jérémie Zerbit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia Hit paper breakdown → | 2020 | 589 |
| 2 | Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial Hit paper breakdown → | 2021 | 229 |
| 3 | 2023 | 47 | |
| 4 | 2022 | 45 | |
| 5 | 2020 | 35 | |
| 6 | 2021 | 28 | |
| 7 | 2021 | 23 | |
| 8 | 2022 | 20 | |
| 9 | 2020 | 17 | |
| 10 | 2021 | 17 | |
| 11 | 2020 | 9 | |
| 12 | 2022 | 9 | |
| 13 | 2024 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2024 | 4 | |
| 16 | 2021 | 3 | |
| 17 | 2022 | 3 | |
| 18 | 2014 | 3 | |
| 19 | 2024 | 1 | |
| 20 | 2024 | 1 |
About Jérémie Zerbit
Jérémie Zerbit is a scholar working on Oncology, Hematology, Pathology and Forensic Medicine, Genetics and Endocrinology, Diabetes and Metabolism, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), COVID-19 and healthcare impacts (3 papers), CAR-T cell therapy research (2 papers), Viral-associated cancers and disorders (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Infectious Diseases (611 citations), Neurology (292 citations), Critical Care and Intensive Care Medicine (32 citations), Hematology (69 citations) and Oncology (119 citations). Jérémie Zerbit has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Justine Decroocq, Didier Bouscary, Jérôme Clerc, Rudy Birsen, Olivier Huillard, Simon Garinet, Béatrix Cochand‐Priollet, Lionel Groussin, Nicolas Chapuis and Éric Grignano. Their work appears in journals such as Thyroid, Cell Death Discovery, EClinicalMedicine, Supportive Care in Cancer and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.